Step forward in quest for norovirus vaccine
Original story from The University of Osaka (Japan). Researchers have developed a simple and efficient system for understanding the functions of specific norovirus genes, providing new avenues for developing antivirals and vaccines. Norovirus is the leading cause of gastroenteritis and is...
Embryonic innovation: demystifying human placenta formation using stem cells
The discovery of a gene essential to early embryonic development sheds light on the preliminary stages of human placenta formation. A team led by scientists from the University of California San Diego (CA, USA) has used human pluripotent stem cells to model the early formation of the placenta,...
The 12 days of BioTechniques: 2025
This holiday season, we are highlighting our top content from the past year in the 12 days of BioTechniques, revealing a key collection of content each day! On the first day of Christmas, my true love gave to me: our most popular article from 2025 NIH freezes rock the research world...
2025 Corporate Security Job Market Shifts
Adaptability is the foundation of resilience, both for corporate security programs and for individual security careers. Continue reading →
The Most Dangerous 6 Weeks of the Year
Attackers are planning around your holidays. The question is whether you’ve done the same. Continue reading →
Lilly’s three-pronged drug puts obesity field ‘on notice’
Lilly’s closely watched retatrutide spurred as much as 29% weight loss in a Phase 3 study, a finding that is “raising the bar” for future obesity drug competitors, one analyst wrote. Continue reading →
Cost Center to Value Driver: How Physical Security Is Transforming
Physical security’s contributions to organizational objectives have increased. Continue reading →
AC Immune posts positive data for Parkinson’s immunotherapy
Shares of AC Immune rose by double-digits on news that the company, encouraged by new data, now intends to ask drug regulators for feedback to “potentially accelerate” the time to an approval filing. Continue reading →
Biotech venture firm Apple Tree goes bankrupt amid dispute with billionaire backer
An unusual tussle over the availability of funds for Apple Tree’s startups led the firm to seek protection from creditors while it restructures. Continue reading →